At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- FinancialsAltman Z-Score 5.87: safe zone
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.61%Below 5Y avg (1.01%)
Annual Rate
INR 1.00Paid annual
Payout Ratio
17.5%Sustainable
Last Ex-Dividend
Feb 17, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
48.18BINR515.71M · vs all stocks (USD)
Trailing P/E
28.70xRevenue (TTM)
25.24BINR270.13M · vs all stocks (USD)
Profit Margin
6.66%Beta
0.5430xvs all stocks
52-Week Change
76.25%vs all stocks
Market Capitalization
48.18BINR515.71M · vs all stocks (USD)
Enterprise Value
47.53BINR508.77M · vs all stocks (USD)
Trailing P/E
28.70xForward P/E
15.78xPEG Ratio
0.3232xPrice to Sales (TTM)
1.91xPrice to Book (MRQ)
2.68xEnterprise to Revenue
1.88xEnterprise to EBITDA
15.26xGross Margin
36.80%Profit Margin
6.66%Operating Margin
10.86%Return on Assets (TTM)
5.32%Return on Equity (TTM)
7.65%Revenue (TTM)
25.24BINR270.13M · vs all stocks (USD)
Revenue per Share (TTM)
85.96INRUpdated Oct 25, 2026Quarterly Revenue Growth
37.10%Gross Profit (TTM)
8.93BINR95.60M · vs all stocks (USD)
EBITDA (TTM)
3.33BINR35.59M · vs all stocks (USD)
Net Income (TTM)
1.68BINR17.99M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
89.80%Operating Cash Flow (TTM)
2.14BINR22.94M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
1.38BINR14.73M · vs all stocks (USD)
Trailing Annual Dividend Rate
1.00INRUpdated Oct 25, 2026Trailing Annual Dividend Yield
0.61%vs all stocks
5-Year Average Dividend Yield
1.01%vs all stocks
Payout Ratio
17.48%Revenue
23.08BINRFY2026 · Mar 31, 2026Cost of Goods Sold
15.16BINRFY2026 · Mar 31, 2026Gross Profit
7.92BINRFY2026 · Mar 31, 2026Operating Income
1.90BINR20.30M · vs all stocks (USD)
Pre-tax Income
1.84BINRFY2026 · Mar 31, 2026Income Tax Expense
467.20MINRFY2026 · Mar 31, 2026Net Income
1.38BINRFY2026 · Mar 31, 2026EBIT
1.94BINRFY2026 · Mar 31, 2026EBITDA (Income Statement)
2.86BINRFY2026 · Mar 31, 2026Selling, General & Administrative
587.90MINRFY2026 · Mar 31, 2026Other Operating Expenses
2.24BINRFY2026 · Mar 31, 2026Non-operating Interest Income
133.10MINRFY2026 · Mar 31, 2026Non-operating Interest Expense
99.90MINRFY2026 · Mar 31, 2026EPS (Basic)
4.69INRFY2026 · Mar 31, 2026EPS (Diluted)
4.69INRFY2026 · Mar 31, 2026Basic Shares Outstanding
293.53MSharesFY2026 · Mar 31, 2026Diluted Shares Outstanding
293.53MSharesFY2026 · Mar 31, 2026Preferred Stock Dividends
0.00INRFY2026 · Mar 31, 2026Operating Cash Flow
1.02BINRFY2026 · Mar 31, 2026Free Cash Flow
-693.30MINRFY2026 · Mar 31, 2026Cash & Cash Equivalents (End of Period)
653.50MINRFY2026 · Mar 31, 2026Starting Profit (CF Statement)
1.84BINRFY2026 · Mar 31, 2026Other Non-cash Items
11.20MINRFY2026 · Mar 31, 2026Change in Accounts Receivable (CF)
-734.60MINRFY2026 · Mar 31, 2026Change in Other Assets/Liabilities
-104.50MINRFY2026 · Mar 31, 2026Capital Expenditures
-1.71BINRFY2026 · Mar 31, 2026Purchase of Investments
-393.20MINRFY2026 · Mar 31, 2026Other Investing Activity
4.80MINRFY2026 · Mar 31, 2026Net Investing Cash Flow
-2.10BINRFY2026 · Mar 31, 2026Net Short-term Debt Issuance
149.60MINRFY2026 · Mar 31, 2026Common Dividends Paid
-293.50MINRFY2026 · Mar 31, 2026Net Financing Cash Flow
-143.90MINRFY2026 · Mar 31, 2026Shares Outstanding
293.53MSharesUpdated Oct 25, 2026Float Shares
82.46MSharesUpdated Oct 25, 2026% Held by Insiders
62.28%vs all stocks
% Held by Institutions
1.85%vs all stocks
Total Cash (MRQ)
2.00BINR21.44M · vs all stocks (USD)
Total Cash per Share (MRQ)
6.82INRUpdated Oct 25, 2026Total Debt (MRQ)
1.35BINR14.50M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0753xCurrent Ratio (MRQ)
1.78xBook Value per Share (MRQ)
61.27INRUpdated Oct 25, 2026Total Assets
25.87BINR276.91M · vs all stocks (USD)
Total Current Assets
12.28BINRFY2026 · Mar 31, 2026Total Liabilities
7.88BINRFY2026 · Mar 31, 2026Total Non-current Assets
13.59BINRFY2026 · Mar 31, 2026Total Non-current Liabilities
982.20MINRFY2026 · Mar 31, 2026Total Current Liabilities
6.90BINRFY2026 · Mar 31, 2026Cash
653.50MINRFY2026 · Mar 31, 2026Cash & Cash Equivalents
653.50MINRFY2026 · Mar 31, 2026Other Short-term Investments
962.10MINRFY2026 · Mar 31, 2026Accounts Receivable
6.03BINRFY2026 · Mar 31, 2026Inventory
3.71BINRFY2026 · Mar 31, 2026Accounts Payable
4.83BINRFY2026 · Mar 31, 2026Short-term Debt
1.33BINRFY2026 · Mar 31, 2026Other Current Liabilities
302.40MINRFY2026 · Mar 31, 2026Long-term Debt
24.00MINRFY2026 · Mar 31, 2026Common Stock (Book)
587.10MINRFY2026 · Mar 31, 2026Retained Earnings
15.10BINRFY2026 · Mar 31, 2026Total Shareholders' Equity
17.99BINR192.52M · vs all stocks (USD)
52-Week Low
67.19INRUpdated Oct 25, 202652-Week High
224.00INRUpdated Oct 25, 202652-Week Change
76.25%vs all stocks
Beta
0.5430xvs all stocks
50-Day MA
193.10INRUpdated Oct 25, 2026200-Day MA
128.91INRUpdated Oct 25, 2026Avg 10-Day Volume
2.39MSharesUpdated Oct 25, 2026Avg 30-Day Volume
3.23MSharesUpdated Oct 25, 2026Diluted EPS (TTM)
5.72INRUpdated Oct 25, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 5.87: safe zoneNotable
Altman Z-Score: 5.87
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Surrozen, Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Blau Farmacêutica S.A.
Tier 1ProductionApproval-Gated PipelineRuleFlow
TaiMed Biologics Inc.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Guangdong Biolight Meditech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Aim Vaccine Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Chengdu Shengnuo Biotech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
CHA Biotech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleInterface
Eiken Chemical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
908 Devices Inc.
Tier 1ProductionApproval-Gated PipelineRule
Shaanxi Kanghui Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow